Incomplete spinal cord injury patients are of special interest for recoveriX because the lesion is not located in the brain, but in the spinal cord. An incomplete spinal cord injury occurs when the spinal cord is only partially damaged, resulting in varying degrees of retained sensory and motor function below the site of the injury. We tested several patients to see if we can produce neuroplasticity in these patients with recoveriX that lead to better motoric functions.
We conducted 25 recoveriX sessions with all the patients, performing both pre-assessments and post-assessments to determine if the treatment led to objective improvements.
The assessment included the following tests:
The data below shows the results of one patient who had an accident approximately two years before the recoveriX treatment. The patient fell from a house roof, affecting his gait. The FMA for Upper Extremity shows the maximum score before and after the therapy as expected.
The FMA for Lower Extremity shows an improvement by 2 points after 25 sessions.
The TUG test improved significantly from 42.56 seconds to 26.88 seconds. Notably, there is a clear trend of improvement, indicating that the patient consistently got better with each treatment.
So far, recoveriX has been tested in 6 patients with incomplete spinal cord injuries, and a clinical study is currently ongoing. We are showcasing the first patient of the study here on the webpage.
You are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information